AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $663 | +24.9% | 9,500 | +28.4% | 0.00% | +50.0% |
| Q2 2023 | $531 | -57.1% | 7,400 | -63.2% | 0.00% | 0.0% |
| Q1 2023 | $1,239 | +322.9% | 20,100 | +428.9% | 0.00% | +100.0% |
| Q4 2022 | $293 | -99.8% | 3,800 | -17.4% | 0.00% | 0.0% |
| Q4 2021 | $173,000 | -2.3% | 4,600 | -14.8% | 0.00% | 0.0% |
| Q3 2021 | $177,000 | +98.9% | 5,400 | +390.9% | 0.00% | – |
| Q4 2020 | $89,000 | -85.8% | 1,100 | -87.5% | 0.00% | -100.0% |
| Q3 2020 | $627,000 | -13.4% | 8,800 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $724,000 | +224.7% | 8,800 | +131.6% | 0.00% | +200.0% |
| Q1 2020 | $223,000 | +1492.9% | 3,800 | +5.6% | 0.00% | – |
| Q1 2017 | $14,000 | -41.7% | 3,600 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -14.3% | 3,600 | 0.0% | 0.00% | – |
| Q3 2016 | $28,000 | +3.7% | 3,600 | -2.7% | 0.00% | – |
| Q2 2016 | $27,000 | – | 3,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |